How to Get Vitrakvi (Larotrectinib) Covered by Humana in New York: PA Requirements, Appeals, and External Review Guide
Answer Box: Getting Vitrakvi Covered by Humana in New York
Vitrakvi (larotrectinib) is covered on Humana's Medicare Advantage formulary but requires prior authorization. Your oncologist must submit documentation proving NTRK gene fusion positivity, metastatic/unresectable disease, and prior therapy history. If denied, you have 65 days to appeal